| Page 595 | Kisaco Research

• Improving global data collection and analytics to provide direction of health equity strategies.

• Discussing pharmaceutical solutions for health equity through clinical trial diversity in the United States.

• Reviewing the global health equity landscape through the lens of regulation and collaboration efforts.

Author:

Denise Bronner

CEO
Empactful Ventures

Denise Bronner

CEO
Empactful Ventures

Author:

Kemi Willaims

Senior Director, Patient Science
AstraZeneca

Kemi Willaims

Senior Director, Patient Science
AstraZeneca

Author:

Keith Dawson

Principal Global Health Equity & Population Science
Genentech

Keith Dawson

Principal Global Health Equity & Population Science
Genentech
 

Jennifer Cunningham-Erves

Associate Professor and Director of Community Engaged Research
Vanderbilt University Medical Center

Jennifer Cunningham-Erves

Associate Professor and Director of Community Engaged Research
Vanderbilt University Medical Center

Jennifer Cunningham-Erves

Associate Professor and Director of Community Engaged Research
Vanderbilt University Medical Center

• Solutions to maximise the implementation of clinical trial & health equity education tools across the clinical trial landscape.

• Deciphering the most effective communication methods for diverse populations.

• Demonstrating how health literacy innovation leads to quality patient experience and improved patient engagement & recruitment.

Author:

LaTrisha Horne

Associate Director of Precision Medicine Implementation
Morehouse School of Medicine

LaTrisha Horne

Associate Director of Precision Medicine Implementation
Morehouse School of Medicine

Author:

Rachel Barron

Senior Manager, Health Equity
Global Genes

Rachel Barron

Senior Manager, Health Equity
Global Genes

Author:

Jennifer Cunningham-Erves

Associate Professor and Director of Community Engaged Research
Vanderbilt University Medical Center

Jennifer Cunningham-Erves

Associate Professor and Director of Community Engaged Research
Vanderbilt University Medical Center
2023 Post-Event Report

Understand the pressure points for enterprises and meet, network and partner with industry leaders from hyperscalers, cloud service providers, enterprises, and investment firms. Our sessions include infrastructure hardware planning, re-imagining data science workflow dynamics, building and training Generative AI models and implementing emerging technologies and AI use cases within both start-up and large enterprise environments.

FIND OUT MORE

Meet your peers working on similar models, other technologists developing internal enterprise models and hyperscalers producing systems at scale. Connect and partner with individuals and companies across the technology and enterprise spectrum to advance and advocate your business's platform and services. Moreover, we have dedicated sessions illustrating the core needs of enterprises in adopting Generative AI techniques and applications and panels by investors deliberating on the next Generative AI investment wave.

FIND OUT MORE

Learn about Generative AI use case product offerings and get a handle on total cost of ownership considerations. Our headline sessions focus on understanding the core business needs and use cases for on-premise and cloud infrastructure, Generative AI return-on-investment (ROI) and presenting use cases for Generative AI cross-department pollination of systems and capabilities. Automating current practices, implementing LLMs, benchmarking AI product progression, and advancing customer service optimizations. Along with discovering possibilities for the next wave of Generative AI applications and the need for greater system interfacing.

LEARN MORE

We have a dedicated track for the most pressing data science issues – discussing AI infrastructure across departments – from managing complex data operations to technical deep dives into reducing token amounts to create efficiency gains. Furthermore, learn from AI model builders how they create robust systems for data compliance, manage model garden offerings and differentiate between proprietary/private and public data sources while considering weights and biases.

FIND OUT MORE

During this session, you'll hear from in-house representatives and vendors about their challenges and solutions in implementing privacy-enhancing technology in various industries. Divided into two tracks for two hours, we will explore SIX PET implementations in real-life scenarios to help you understand the applicability of PET to your organization. By the end of this session, you'll have gained insights into successful and unsuccessful PET implementation strategies and be better equipped to implement PET in your organization.

Author:

Tracy DeTomasi

CEO
Callisto

Tracy DeTomasi

CEO
Callisto